{"id":103168,"date":"2024-07-25T15:30:00","date_gmt":"2024-07-25T13:30:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=103168"},"modified":"2024-07-25T14:52:50","modified_gmt":"2024-07-25T12:52:50","slug":"series-d-financing-for-catalym","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/103168\/series-d-financing-for-catalym\/","title":{"rendered":"Series D financing for Catalym"},"content":{"rendered":"<div class=\"entry-content\">\n<p><a href=\"\/en\/day\/catalym\/\">Catalym<\/a> secures \u20ac138 million (USD150 million) in a Series D financing round. The oversubscribed financing round was led by new investors Canaan Partners and Bioqube Ventures, and joined by Forbion&#039;s Growth Opportunities Fund, Omega Funds, and Gilde Healthcare. Existing investors Jeito Capital, Brandon Capital Partners, Novartis Venture Fund, and Vesalius Biocapital III also participated in the round. The fresh capital will be used to finance the Phase 2b development of visugromab for the treatment of various cancers.<\/p>\n\n\n\n<p>The drug candidate Visugromab is designed to neutralize a specific protein that tumors use to protect themselves from the body&#039;s immune system. This should make tumors accessible to the immune system again, thus strengthening the immune response. <strong>Phil L&#039;Huillier<\/strong>, Managing Director and Chief Executive Officer at Catalym, commented on the current financing round:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>&quot;This substantial capital raise and strong syndicate are a recognition of our achievements as a company and underscore the outstanding results of visugromab and our broad Phase 2b clinical program. We continue to demonstrate the potential of visugromab to induce deep and durable cancer remission in multiple solid tumor indications, underscoring the important role visugromab could play in a novel cancer therapy. We are building significant momentum for Catalym&#039;s development strategy and look forward to the support of these high-caliber new and existing international investors who share our vision of breaking through immunosuppressive barriers to improve therapeutic outcomes.&quot;<\/p>\n<\/blockquote>\n\n\n\n<p>In conjunction with the closing of the financing, Colleen Cuffaro, Partner at Canaan; Jon Edwards, Managing Partner at Bioqube Ventures; and Otello Stampacchia, Managing Director and Founder at Omega Funds, will join Catalym&#039;s Board of Directors. Stefan Luzi, Partner at Gilde Healthcare, will serve as an observer. <strong>Colleen Cuffaro<\/strong>, partner at <a href=\"https:\/\/www.canaan.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Canaan Partners<\/a>, says:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>&quot;The data recently presented at ASCO underscore the highly differentiated therapeutic profile of visugromab and validate Phil and his team&#039;s ability to rapidly execute the company&#039;s clinical plan. As the company moves into expanded Phase 2b development, we look forward to providing strategic guidance on the company&#039;s path to transforming current treatment options for difficult-to-treat solid tumor indications.&quot;<\/p>\n<\/blockquote>\n\n\n\n<p><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Biotech startup Catalym successfully closes its \u20ac138 million Series D financing round. The financing round was led by Canaan Partners and Bioqube Ventures.<\/p>","protected":false},"author":24,"featured_media":66785,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[4129,52],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Series-D-Finanzierung f\u00fcr Catalym - Munich Startup<\/title>\n<meta name=\"description\" content=\"Catalym schlie\u00dft seine Series-D-Finanzierungsrunde erfolgreich ab. Die Finanzierungsrunde wurde von Canaan Partners und Bioqube Ventures angef\u00fchrt.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/103168\/series-d-financing-for-catalym\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Series-D-Finanzierung f\u00fcr Catalym - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Catalym schlie\u00dft seine Series-D-Finanzierungsrunde erfolgreich ab. Die Finanzierungsrunde wurde von Canaan Partners und Bioqube Ventures angef\u00fchrt.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/103168\/series-d-financing-for-catalym\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-25T13:30:00+00:00\" \/>\n<meta name=\"author\" content=\"Regina Bruckschl\u00f6gl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Regina Bruckschl\u00f6gl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/\",\"url\":\"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/\",\"name\":\"Series-D-Finanzierung f\u00fcr Catalym - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/11\/medic-563423_1920.jpg\",\"datePublished\":\"2024-07-25T13:30:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\"},\"description\":\"Catalym schlie\u00dft seine Series-D-Finanzierungsrunde erfolgreich ab. Die Finanzierungsrunde wurde von Canaan Partners und Bioqube Ventures angef\u00fchrt.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/11\/medic-563423_1920.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/11\/medic-563423_1920.jpg\",\"width\":1920,\"height\":1280,\"caption\":\"Catalym\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Series-D-Finanzierung f\u00fcr Catalym\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\",\"name\":\"Regina Bruckschl\u00f6gl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"caption\":\"Regina Bruckschl\u00f6gl\"},\"description\":\"Nach eigenen Startup-Erfahrungen blickt sie als Redakteurin von Munich Startup nun aus einer anderen Perspektive auf die M\u00fcnchner Startup-Szene \u2013 und entdeckt dabei jeden Tag, wie vielf\u00e4ltig das M\u00fcnchner \u00d6kosystem ist. Startup Stories, die erz\u00e4hlt werden wollen!\",\"sameAs\":[\"https:\/\/cms.munich-startup.net\"],\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/regina\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2020\/11\/medic-563423_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Series D financing for Catalym - Munich Startup","description":"Catalym successfully closes its Series D financing round. The financing round was led by Canaan Partners and Bioqube Ventures.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/103168\/series-d-financing-for-catalym\/","og_locale":"en_US","og_type":"article","og_title":"Series-D-Finanzierung f\u00fcr Catalym - Munich Startup","og_description":"Catalym schlie\u00dft seine Series-D-Finanzierungsrunde erfolgreich ab. Die Finanzierungsrunde wurde von Canaan Partners und Bioqube Ventures angef\u00fchrt.","og_url":"https:\/\/cms.munich-startup.net\/en\/103168\/series-d-financing-for-catalym\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2024-07-25T13:30:00+00:00","author":"Regina Bruckschl\u00f6gl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Regina Bruckschl\u00f6gl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/","url":"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/","name":"Series D financing for Catalym - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/11\/medic-563423_1920.jpg","datePublished":"2024-07-25T13:30:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f"},"description":"Catalym successfully closes its Series D financing round. The financing round was led by Canaan Partners and Bioqube Ventures.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/11\/medic-563423_1920.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/11\/medic-563423_1920.jpg","width":1920,"height":1280,"caption":"Catalym"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/103168\/series-d-finanzierung-fuer-catalym\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Series-D-Finanzierung f\u00fcr Catalym"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f","name":"Regina Bruckschl\u00f6gl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","caption":"Regina Bruckschl\u00f6gl"},"description":"After her own startup experiences, she now looks at the Munich startup scene from a different perspective as an editor at Munich Startup \u2013 and discovers every day how diverse the Munich ecosystem is. Startup stories that beg to be told!","sameAs":["https:\/\/cms.munich-startup.net"],"url":"https:\/\/cms.munich-startup.net\/en\/author\/regina\/"}]},"og_image":[{"width":1920,"height":1280,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/11\/medic-563423_1920.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1721911971:24","_edit_last":"24","_yoast_wpseo_focuskw":"Catalym","_yoast_wpseo_metadesc":"Catalym schlie\u00dft seine Series-D-Finanzierungsrunde erfolgreich ab. Die Finanzierungsrunde wurde von Canaan Partners und Bioqube Ventures angef\u00fchrt.","_yoast_wpseo_linkdex":"62","_thumbnail_id":"66785","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"90","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/103168"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=103168"}],"version-history":[{"count":4,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/103168\/revisions"}],"predecessor-version":[{"id":103444,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/103168\/revisions\/103444"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/66785"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=103168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=103168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=103168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}